Birmingham News and Rochester's Democrat and Chronicle have recently published an op-ed by Michael J. Fox that focuses on the critical role clinical trial volunteers play in advancing Parkinson's research.
The Paracelsus-Elena Klinik in Kassel, German, is featured in the Hessische Allgemaine. This article was originally published in German, and has been translated into English.
A new page has been added to the website to show the number of data downloads and specimen requests, as well as where people who download the data are from globally and by sector.
PPMI study leadership is repeating a qualification study in controls that was completed last fall with a group of PD subjects and older controls to detect changes in biomarkers over the course of a day.
Fall kicks off to a great start as PPMI passes the 200th subject mark, one third of the way to meeting the study's recruitment goal.
The Bioanalytics core of PPMI recently organized the first interlaboratory study to assess the within-center precision of immunoassays for a-SYN measurement in CSF. The long term goal of these studies to optimize and validate an a-SYN biomarker assay for use in the PPMI and other research biomarker studies of PD and PDD as well as to set the stage for wider clinical use of these diagnostic assays beyond specialized research centers. The initial results of these detailed statistical analyses were discussed amongst the participants and will be discussed at the MJFF-hosted PD Therapeutics meeting.